A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease.

@article{Grosso2015ATA,
  title={A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease.},
  author={Dolores A Grosso and Sameh Gaballa and Onder S Alpdogan and Matthew Carabasi and Joanne Filicko-O'Hara and Margaret T. Kasner and Ubaldo e. Martinez-outschoorn and John L. Wagner and William O'Hara and Shannon E Rudolph and Inna Chervoneva and Beth W Colombe and Patricia Cornett Farley and Phyllis R Flomenberg and Barbara Pro and M. Ramakrishna Sharma and Wenyin Shi and Mark A. Weiss and Neal Flomenberg},
  journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation},
  year={2015},
  volume={21 4},
  pages={646-52}
}
Haploidentical hematopoietic stem cell transplantation (HSCT) is an attractive alternative donor option based on the rapid availability of an acceptable donor for most patients and decreased cost compared with costs of other alternative donor strategies. The safety of haploidentical HSCT has increased in recent years, making it ethically feasible to offer to patients with earlier stage disease. We developed a 2-step approach to haploidentical HSCT that separates the lymphoid and myeloid… CONTINUE READING
14 Citations
26 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Census: Big decline in nuclear family

  • E. Babay
  • November 26,
  • 2013
1 Excerpt

Similar Papers

Loading similar papers…